Riyadh — Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) saw a negotiated (special) deal executed during the 6 September trading session on the Saudi Exchange (Tadawul) at a value of SAR 94.99 million.
The transaction was implemented over 3.40 million shares at SAR 27.9 per share.
Negotiated deals are executed off the order book between two parties; the figures reflect reported trade data and do not constitute investment advice.
In the second quarter (Q2) of 2026, the Saudi pharmaceutical group logged net profits valued at SAR 68.40 million.
